Longitudinal risk of serious infections in patients with inflammatory arthritis on immunomodulating therapy compared to controls.

Rheumatol Adv Pract · 2025 · PMC11889454 · PMID 40061449

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

We found that the risk of serious infections was consistently lower during the treatment course in PsA/SpA vs RA patients, but this did not reach statistical significance ( Supplementary Table S4 , available at Rheumatology Advances in Practice online).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.